Literature DB >> 32536287

Role of vacuolating cytotoxin A in Helicobacter pylori infection and its impact on gastric pathogenesis.

Shamshul Ansari1, Yoshio Yamaoka2,3,4,5.   

Abstract

Introduction Helicobacter pylori causes, via the influence of several virulence factors, persistent infection of the stomach, which leads to severe complications. Vacuolating cytotoxin A (VacA) is observed in almost all clinical strains of H. pylori; however, only some strains produce the toxigenic and pathogenic VacA, which is influenced by the gene sequence variations. VacA exerts its action by causing cell vacuolation and apoptosis. We performed a PubMed search to review the latest literatures published in English language. Areas covered Articles regarding H. pylori VacA and its genotypes, architecture, internalization, and role in gastric infection and pathogenicity are reviewed. We included the search for recently published literature until January 2020. Expert opinion H. pylori VacA plays a crucial role in severe gastric pathogenicity. In addition, VacA mediated in vivo bacterial survival leads to persistent infection and an enhanced bacterial evasion from the action of antibiotics and the innate host defense system, which leads to drug evasion. VacA as a co-stimulator for the CagA phosphorylation may exert a synergistic effect playing an important role in the CagA-mediated pathogenicity.

Entities:  

Keywords:  H. pylori ; VacA; VacA-mediated apoptosis; pathogenicity; vacuolation

Mesh:

Substances:

Year:  2020        PMID: 32536287     DOI: 10.1080/14787210.2020.1782739

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  8 in total

Review 1.  Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Clin Microbiol Rev       Date:  2022-04-11       Impact factor: 50.129

Review 2.  The Implication of Gastric Microbiome in the Treatment of Gastric Cancer.

Authors:  George Pappas-Gogos; Kostas Tepelenis; Fotis Fousekis; Konstantinos Katsanos; Michail Pitiakoudis; Konstantinos Vlachos
Journal:  Cancers (Basel)       Date:  2022-04-18       Impact factor: 6.575

3.  Effect of Probiotic-Assisted Eradication of cagA+/vacA s1m1 Helicobacter pylori on Intestinal Flora.

Authors:  Chenxi He; Fanting Kong; Xiukun Chai; Chunyan Zou; Xinying Zhu; Dongqiang Zhao
Journal:  Biomed Res Int       Date:  2022-04-29       Impact factor: 3.246

Review 4.  Role of Bacteria in the Incidence of Common GIT Cancers: The Dialectical Role of Integrated Bacterial DNA in Human Carcinogenesis.

Authors:  Sayed K Elagan; Saad J Almalki; M R Alharthi; Mohamed S Mohamed; Mohamed F El-Badawy
Journal:  Infect Drug Resist       Date:  2021-06-01       Impact factor: 4.003

Review 5.  Helicobacter pylori-Mediated Oxidative Stress and Gastric Diseases: A Review.

Authors:  Lu Han; Xu Shu; Jian Wang
Journal:  Front Microbiol       Date:  2022-02-08       Impact factor: 5.640

6.  Statistical proof of Helicobacter pylori eradication in preventing metachronous gastric cancer after endoscopic resection in an East Asian population.

Authors:  Mohsen Karbalaei; Masoud Keikha
Journal:  World J Gastrointest Surg       Date:  2022-08-27

Review 7.  Helicobacter pylori Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity.

Authors:  Shamshul Ansari; Yoshio Yamaoka
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923

8.  Myricetin as an Antivirulence Compound Interfering with a Morphological Transformation into Coccoid Forms and Potentiating Activity of Antibiotics against Helicobacter pylori.

Authors:  Paweł Krzyżek; Paweł Migdał; Emil Paluch; Magdalena Karwańska; Alina Wieliczko; Grażyna Gościniak
Journal:  Int J Mol Sci       Date:  2021-03-07       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.